About

Sapporo Medical Journal

Sapporo Medical Journal is an open access, monthly, peer reviewed International Medical Journal with focuses on publishes research conducted in all fields of medical, medicine. There is no restriction on the length of research papers and reviews, although authors are encouraged to be concise. Sapporo Medical Journal is a scopus indexed International Medical Journal that wants to publish original articles, research articles, review articles with top-level work from all areas of Medicine, General Medicine, Medical Science Research and their application including Aetiology, bioengineering, biomedicine, cardiology, chiropody etc.
Sapporo Medical Journal
Sapporo Medical Journal
Sapporo Medical Journal
Sapporo Medical Journal
Sapporo Medical Journal
Sapporo Medical Journal
Sapporo Medical Journal
Sapporo Medical Journal
Sapporo Medical Journal
Sapporo Medical Journal
Sapporo Medical Journal

Sapporo Medical Journal aims to distribute and expand medical data to the World as well as build a supportive and vibrant community of researchers to connect and explore ideas by publishing articles related to all fields of medicine. Sapporo Medical Journal believes that quality and ethical research. The journal seeks to publish original research articles that are hypothetical and theoretical in its nature and that provide exploratory insights in the following fields but not limited to:

Medicine Microbiology Biochemistry Pharmacology Pathology Forensic medicine Internal Medicine Physiology Anatomy Obstetrics and Gynecology Radiology Community Medicine Otorhinolaryngology Infectious Diseases General Surgery Cancer research Pulmonary Dermatology and Venereal diseases Orthopedics Neurology Anaesthesia Medical education Infectious Diseases and Vaccinology Neurosurgery Gastroenterology Nephrology Paediatrics Reproduction Dental Cardiology Surgery Nursing Otolaryngology Dermatology Diabetes Orthopaedics Hepatology Urology Psychology Anesthesiology Endocrinology Biotechnology Venereology ENT Psychiatry Pharmaceutical Analysis Pharmacy Pharmaceutical Chemistry Pulmonology Pharmaceutics Pharmaceutical Pharmacognosy Biopharmaceutics Phatmaceutical Technology Quality Assurance Pharmacodynamics Pharmacokinetics Drug Regulatory Industrial Pharmacy Pharmaceutical Nanotechnology Drug Design Affairs Phytochemistry Drug Delivery Systems Drug Discovery Pharmaceutical Microbiology Pharmacy Practice Hospital Pharmacy Clinical Pharmacy Pharmacogenomics Drug Metabolism Pharmacovigilance Toxicology Clinical Research Microbiology Phrmacoinformatics Life Sciences like Chemistry Epidemiology Biomedical Sciences Immunology Dentistry Oncology Biomedicine Physiotherapy Sexology Neuroscience Gynaecology Dermatoepidemiology Pharmacy and Nursing Angiology/Vascular Medicine Osteology Ophthalmology Haematology Kinesiology Critical care Medicine Pharmacognosy and Phytochemistry Clinical immunology Bariatrics Genomics and Proteomics Clinical and Hospital Pharmacy Radiobiology Cell Biology Geriatric Medicine Healthcare Services Healthcare Management Bioinformatics and Biotechnology
Paper ID : SMJ2409205408130
Sapporo Medical Journal
Author : I Ketut Alit Utamayasa, Mahrus Abdur Rahman, Taufiq Hidayat, Feranti Meuthia2,

Abstract : Ventricular septal defects (VSDs) are a common congenital heart disease (approximately 20%). The most common are the perimembranous VSD (around 70%), while completely muscular VSD may occur around 15% of the cases. Supracrystal defects are quite rare accounting for 5% of all VSD. Indications to VSD closure are symptoms of heart failure, signs of left heart chambers overload, and history of endocarditis. The traditional treatment is surgical repair. The surgical approach is considered to be the gold standard, but it is associated with morbidity and mortality, patient discomfort, sternotomy and skin scar. Percutaneous techniques have been developed in order to reduce the impact of such drawback of surgery. Since the first VSD closed by a transcatheter approach by Lock et al. various techniques have been used. Closure of VSD using Ampatzer occluders has been greatly improved and widely reported. VSD inselected patients may be closed percutaneously using an Amplatzer Ductal Occluder II (ADO II) device, as an off-label therapy. It appears that ADO II may be the preferable device for the closure of defects of moderate size (2-5 mm), especially in infants and small children, because of its better profile.

Paper ID : SMJ2409205408129
Sapporo Medical Journal
Author : Bagus Setyoboedi, Ahmad Mahfur, Alphania Rahniayu, Anang Endaryanto, Sjamsul Arief,

Abstract : Background: Biliary Atresia (BA) is still a challenge because its pathogenesis remains unclear. It is suggested that interferon gamma (IFN-𝛾) has important role in its pathogenesis. Aims: To analyze correlation between IFN-𝛾 expression, cholestasis grading, and biliary atresia incidence in neonatal cholestasis. Methods: It is an analytic observational study within neonatal cholestasis subjects 1-12 months age. Liver biopsies were performed on these subjects. Subjects were divided into biliary atresia and non-biliary atresia according to its histopathology. Then, cholestasis severity were analyzed in its liver specimens and divided into mild, moderate and poor groups. Immunohistochemistry were performed to all of the specimens. Spearman Rank test, Eta Contingency, and Coefficient contingency were performed as statistical tests. Results: There were 34 subjects consists of 20 biliary atresia and 14 non biliary atresia. The average IFN-𝛾 expression in BA group was 11 ± 3.145 cells whereas in non-BA group was 5.928±1.439 cells. Cholestasis severity in BA group were mild (0%), moderate (5%) and 95% had poor grade whereas in non BA group were 21.43%, 50%, and 28.57% respectively. There was significant correlation between IFN-𝛾 expression and BA incidence (r=0,904; p=0,00). There was significant correlation between IFN-𝛾 expression and cholestasis severity grades (r=0,639; p=0,000). There was significant correlation between cholestasis severity grades and BA incidence (r=0,574;

Paper ID : SMJ2309205408124
Sapporo Medical Journal
Author : Amir-Reza Dalili, Banafsheh Ghavidel-parsa, Saeid Sadeghi Joni, Poupak Tohidi Kaloorazi, Seyyed Mohammad Mousavi, Yasaman Soleimanmanesh, Nazanin Soleimanmanesh,

Abstract : Introduction: Rheumatoid arthritis is a common and systemic disease for unknown reasons. Pulmonary involvement is common in patients with rheumatoid arthritis. Lung ultrasound is a safe, easy, and accessible way to diagnose lung cancer. Therefore, the aim of this study was to investigate the diagnostic accuracy of pulmonary ultrasound (US) to find pulmonary parenchymal involvement in patients in patients with rheumatoid arthritis. Materials and Method: This study was performed cross-sectionally with a descriptive-analytical approach on 123 patients with rheumatoid arthritis. After obtaining written consent, all individuals were undergoing lung ultrasound. The results of ultrasound to determine the diagnostic accuracy of this modality in ILD diagnosis, were compared with the findings of HRCT. In the next step, a checklist also included personal information such as gender, age, smoking and drug history for each patient. The collected data were analyzed after coding and logging into SPSS-21 statistical software and analyzed using appropriate statistical tests. Results: Evidence of ILD in HRCT study was observed in 37 subjects (about 30%). Sensitivity and specificity in ILD diagnosis were 64.8% and 60.47%, respectively. The positive predictive value (PPV), negative predictive value (NPV), positive odds ratio and negative odds ratio were estimated at 41.38%, 80%, 1.64, 0.58, respectively and diagnostic accuracy was 61.79%. Ultrasound sensitivity in both mild and moderate B-Line w

Paper ID : SMJ2209205408123
Sapporo Medical Journal
Author : Roro Nur Fauziyah, Sudijanto Kamso, Budhi Setianto, Purwantyastuti, Osman Syarief, Surmita, Heni Hendriyani, Gurid PE Mulyo,

Abstract : Background: Adult Treatment Panel III (ATP III) Metabolic Syndrome Incidence of the National Cholesterol Education Program at 40 years and above 24 % and WHO 21 %. The prevalence of metabolic syndrome in the US was 25 %, 31 % in Padang City, Jakarta, and 21.6 %. Fermented black glutinous rice has a phenolic, flavonoid, anthocyanin, and fiber component believed to prevent regulated metabolic syndrome. Objective: This study aimed to determine the relationship between fermented black glutinous rice consumption and the prevention of metabolic syndrome at age 40 and above in West Bandung Regency, West Java Province. Design: The research used a case-control design. Samples in this study were respondents aged 40 years and over in West Bandung, West Java province, with 57 cases and 57 controls. Data were collected through interviews and physical examinations. Results: The cut-off point at least daily intake of fermented black glutinous rice can prevent the occurrence of metabolic syndrome by more than 11,5 grams per day. The percentage of metabolic syndrome is greater than the proportion of respondents who eat black fermented glutinous rice ≤11.5 grams a day (82.1 a cent). The proportion of non-metabolic syndrome was higher among respondents who used fermented black gluten. Conclusion: It can be inferred that people who eat more than 11,5 grams a day of fermented black glutinous rice have a preventive effect on the occurrence of metabolic syndrome nine times with control variables of

Paper ID : SMJ2209205408122

Abstract : Congenital heart disease causes pulmonary arterial hypertension, heart failure, and early death. Pulmonary arterial hypertension causes pulmonary arterial wall remodeling, inflammation, deposition of extracellular matrix protein, collagen synthesis, and fibrosis. This study aims to analyze the effect of Pomegranate extract on pulmonary arterial pressure in Sprague Dawley rats with pulmonary arterial hypertension. Twenty-four Sprague Dawley rat age 3-month bodyweight 250-350 gram allocated randomly into Pomegranate extract and control group, 6 rats in each group. Pulmonary arterial hypertension.was induced with monocrotaline 60 mg/kg body weight injected subcutaneously. Pulmonary arterial pressure both groups were measured at 2 weeks and 4 weeks of observation. Rats were euthanized after 2 and 4 weeks of observation. Mean pulmonary arterial pressure the Pomegranate extract group was significantly lower compared to the control group in two weeks and four weeks of observation, 27,57±9,17 mmHg vs 47,48±5,58 mmHg (p=0.001) and 32,43±9,64 mmHg vs 46,53±5,53 mmHg (p=0.001) respectively. Pomegranate extract can decrease pulmonary arterial pressure in Sprague Dawley rats with pulmonary arterial hypertension induced by monocrotaline. Pomegranate extracts effective preventing the progressivity of pulmonary arterial hypertension in the rat.